The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey-Reference-Cited by-同舟云学术

The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey

Published:2021-05-24 Issue: Volume: Page:1-8
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Kartal Selda Pelin¹^ORCID,Çelik Gökçen²,Yılmaz Oğuz³,Öksüm Solak Eda⁴,Demirbağ Gül Büşra⁵,Üstünbaş Tuba Kevser⁶,Gönülal Melis⁷^ORCID,Baysak Sevim⁸^ORCID,Yüksel Esma İnan⁹,Ünlü Begüm¹⁰,Güven Münevver¹¹,Bozdağ Ali¹²,Çınar Gökhan¹³,Kartal Selim¹⁴,Borlu Murat⁴,Özden Müge Güler⁵,Engin Burhan⁶,Serdaroğlu Server⁶,Balcı Didem Didar⁷,Doğan Bilal¹⁵,Çiçek Demet⁹,Yazıcı Ayça Cordan¹⁰,Aytekin Sema¹⁶,Şendur Neslihan¹¹,Sarıcaoglu Hayriye¹²,Kaçar Nida Gelincik¹³,Doğramacı Asena Cigdem¹⁴,Dönmez Levent¹⁷^ORCID,Alpsoy Erkan³

Affiliation:

1. Department of Dermatology, University of Health Sciences Turkey, Dışkapı Education and Research Hospital, Ankara, Turkey

2. Polatlı State Hospital, Dermatology Clinic, Ankara, Turkey

3. Department of Dermatology, Akdeniz University Faculty of Medicine, Antalya, Turkey

4. Department of Dermatology, Erciyes University Faculty of Medicine, Kayseri, Turkey

5. Department of Dermatology, Ondokuzmayıs University Faculty of Medicine, Samsun, Turkey

6. Department of Dermatology, Cerrrahpaşa University, Faculty of Medicine, Istanbul, Turkey

7. Tepecik Education and Research Hospital Department of Dermatology, University of Health Sciences Turkey, İzmir, Turkey

8. Department of Dermatology, University of Health Sciences Turkey, Sultan 2. Abdulhamid Han Education and Research Hospital, İstanbul, Turkey

9. Department of Dermatology, Fırat University Faculty of Medicine, Elazığ, Turkey

10. Department of Dermatology, Mersin University Faculty of Medicine, Mersin, Turkey

11. Department of Dermatology, Aydın Adnan Menderes University Faculty of Medicine, Aydın, Turkey

12. Department of Dermatology, Uludağ University Faculty of Medicine, Bursa, Turkey

13. Department of Dermatology, Pamukkale University Faculty of Medicine, Denizli, Turkey

14. Department of Dermatology, Mustafa Kemal University Faculty of Medicine, Hatay, Turkey

15. Department of Dermatology, Maltepe University Faculty of Medicine, Istanbul, Turkey

16. Department of Dermatology, University of Health Sciences Turkey, Haydarpaşa Education and Research Hospital, Istanbul, Turkey

17. Department of Public Health, Akdeniz University Faculty of Medicine, Antalya, Turkey

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2021.1927947

Reference38 articles.

1. COVID‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

2. Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists

3. National Psoriasis Foundation. NPF Forms COVID-19 Task Force. 2020. https://www.psoriasis.org/advance/coronavirus. Accessed on January 20, 2021.

4. European Academy of Dermatology and Venereology. Management of Psoriasis Under Systemic Treatments. 2020. https://www.eadv.org/cms-admin/showfile/7_PSORİASİS-SPIN%20TF%20Recommendations_Covid-Corner.pdf. Accessed on January 20, 2020.

5. Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus‐based guidance for clinical decision‐making during the COVID‐19 pandemic

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Psoriasis Patients with Serious Infectious Diseases;Advances in Therapy;2024-05-06

2. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries;Psoriasis: Targets and Therapy;2024-05

3. Enhanced impact of psoriasis severity on the treatment demands of patients during the COVID-19 pandemic: a cross-sectional study based on a national psoriasis registry in China;BMJ Open;2024-02

4. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30

5. The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study;Dermatologic Therapy;2023-12-26